You never thought you would find yourself living in a society where 2 or 3 year-olds were legally high on amphetamines every day, did you?
Recently in Psychiatry Category
February 1, 2015
By : Eevee G
Alcoholism is one of the most dangerous and common addictions of our time. The World Health Organization’s statistics show that over 140 million people worldwide are suffering from it. Alcoholism-related illnesses are the cause of death of more than 80,000 people a year in the US and of over 3 million people in the world. This makes it one of the first preventable causes of death (nearly 6% of all deaths are related to alcoholism).
With so many people having to deal with the problems of such kind of addiction, different studies have been held in order a reliable treatment to be found. One of the most recent studies, conducted at the University of New Mexico, found that using psilocybin can be an excellent way to treat alcoholism. Some of the people who were a part of the research team were Dr. Michael Bogenschutz and Dr. Rick Strassman- the author of “DMT: The Spirit Molecule” who has previously done research on DMT in the 1990s.
The Mental Health Watchdog
January 7, 2015
“All classes of psychiatric drugs can cause brain damage and lasting mental dysfunction when used for months or years” — Dr. Peter Breggin
American Free Press, January 6, 2014
by Peter Breggin, Psychiatrist
"All classes of psychiatric drugs cause serious and dangerous withdrawal reactions, and again, it is prudent and safest to assume that any psychiatric drug can cause withdrawal problems. Meanwhile, there is no substantial or convincing evidence that any psychiatric drug is useful longer-term. Psychiatric drug treatment for months or years lacks scientific basis. Therefore, the risk-benefit ratio is enormously lopsided toward the risk."
Psychiatric drugs are more dangerous than you have ever imagined. If you haven’t been prescribed one yet, you are among the lucky few. If you or a loved one are taking psychiatric drugs, there is hope, but you need to understand the dangers and how to minimize the risk.
by Jon Rappoport
I’ve published much information revealing psychiatry is a scientific fraud. Now, courtesy of Dr. Fred Baughman (ADHDfraud.net), I have two more smoking guns.
The first is a letter, dated November 10, 2008, sent from Supriya Sharma, MD, a director general of Health Canada, to a private citizen (name withheld).
Health Canada is the equivalent of the FDA in America.
Dr. Sharma is “responding on the Minister’s behalf”—the Health Minister of Canada, a post roughly comparable to the US Secretary of Health and Human Services.
Here is Dr. Sharma’s key passage:
“For mental/psychiatric disorders in general, including depression, anxiety, schizophrenia, and ADHD, there are no confirmatory gross, microscopic or chemical abnormalities that have been validated for objective physical diagnosis.”
By Kelly Patricia O’Meara
June 9, 2013
“Mental health, psychiatric drugs and violence are the common denominator among the growing list of killers. How many more have to die before the mental health industry is held responsible, and accountable, for this deadly 'treatment?'”
In the last forty-five days there have been three violent killing sprees committed by young men whose only common denominator is a history of mental health services and psychiatric drug use. Given that this is becoming the norm, rather than the exception, one can only wonder how long the mental health community can get away with feigning no responsibility for these ever-increasing senseless acts of violence?
The alleged Seattle Pacific University killer, Aaron Ybarra, is the most recent example of perpetrators with mental health histories and prescribed mind-altering psychiatric drugs as “treatment.” Ybarra’s history includes multiple encounters with the mental health industry and, according to Ybarra himself, he had been taking the antidepressant Prozac and an anti-psychotic Risperdal, to help him with his problems.
By ALAN SCHWARZMAY
May 16, 2014
Susanna N. Visser presented a report on Friday at the Georgia Mental Health Forum in
Atlanta on the diagnosis and medication for A.D.H.D. in young children.
Credit Dustin Chambers for The New York Times
ATLANTA — More than 10,000 American toddlers 2 or 3 years old are being medicated for attention deficit hyperactivity disorder outside established pediatric guidelines, according to data presented on Friday by an official at the Centers for Disease Control and Prevention.
The report, which found that toddlers covered by Medicaid are particularly prone to be put on medication such as Ritalin and Adderall, is among the first efforts to gauge the diagnosis of A.D.H.D. in children below age 4. Doctors at the Georgia Mental Health Forum at the Carter Center in Atlanta, where the data was presented, as well as several outside experts strongly criticized the use of medication in so many children that young.
The American Academy of Pediatrics standard practice guidelines for A.D.H.D. do not even address the diagnosis in children 3 and younger — let alone the use of such stimulant medications, because their safety and effectiveness have barely been explored in that age group. “It’s absolutely shocking, and it shouldn’t be happening,” said Anita Zervigon-Hakes, a children’s mental health consultant to the Carter Center. “People are just feeling around in the dark. We obviously don’t have our act together for little children.”
April 30, 2012
It's a sign of the times where the medicalization of almost every human behavior is being documented, labeled and categorized as some type of illness or 'disorder.' A psychiatrist who heads the National Institute of Mental Health (NIMH) wants to broaden the definition of children with mental illness so that unruly and badly behaved kids will soon be diagnosed as having mental disorders.
It's not terribly shocking anymore to have some so-called expert, academic or psychiatrist label perfectly normal human behaviors as disorders. What a coincidence that this one happens to head the NIMH.
"One reason we haven't made greater progress helping people recover from mental disorders is that we get on the scene too late," said Thomas R. Insel, MD, director of the NIMH and the featured speaker at the American Academy of Pediatrics' Presidential Plenary during the Pediatric Academic Societies (PAS) annual meeting in Boston.
January 30th 2014
By: Sayer Ji, Founder
As far back as 1954, reports of the full or partial resolution of schizophrenia following a gluten free diet began to surface in the medical literature. We covered this remarkable pattern of associations in a previous article titled, "60 Years of Research Links Gluten Grains to Schizophrenia ." While the explanation for this intriguing connection has remained focused on the disruption of the gut-brain axis and the presence in wheat of a wide range of pharmacologically active and mostly opioid receptor modulating polypeptides, a new and possibly more disturbing explanation is beginning to surface: wheat consumption cuts off blood flow to the brain.
Starting with a 1997 case study published in the Journal of Internal Medicine involving a 33-year-old patient, with pre-existing diagnosis of 'schizophrenic' disorder, who first came to medical attention for severe diarrhea and weight loss (classical symptoms of gluten intolerance), brain scan technology determined that cerebral hypoperfusion (decreased blood flow to the brain) was occurring within the patient's frontal cortex.[i] A gluten free diet resulted not only in the normalization of intestinal damage and autoantibodies, but the return of blood flow to the frontal cortex, and the resolution of schizophrenic symptoms.
January 21st 2014
By: Dr. Kelly Brogan, M.D.
Every functional medicine psychiatrist has case stories of the 'probiotic cure' – of a patient with debilitating symptoms, often obsessive compulsive range, whose symptoms remitted completely with dietary change and probiotic supplementation. Is this voodoo or is it based on a growing understanding of the role of the microbiome in mental health and behavior ? For two decades now, pioneering researchers have been substantiating inflammatory models of mental illnesses such as depression, bipolar disorder, and schizophrenia. Research has focused on markers that indicate immune distress in an important subset of patients, many of whom are labeled "treatment resistant." Through this body of literature, we have identified that depression can be induced, in animals and in humans through inflammatory agents, that it is correlated with blood levels of inflammatory markers, in a linear way (more markers = worse depression), and that symptoms can be reversed through pharmaceutical anti-inflammatories.
The more significant point of the study, which it never discusses, is that it demonstrates that psychiatric drugs are killing people at a rate as much as 13½ times the rest of the population!
Marijuana has often been demonized as causing schizophrenia, though a cause-and-effect connection has never been shown. Now, though, a new study published in the Journal of Psychiatric Research has documented that people diagnosed with schizophrenia who use marijuana—also called pot or cannabis—live longer than those who don’t, and alcohol use has no impact on lifespan. The authors concluded:
To our knowledge, this is one of the first studies to examine the risk of mortality with cannabis and alcohol in people with PD (psychotic disorders). This interesting finding of decreased mortality risk … in cannabis users is a novel finding and one that will need replication in larger epidemiological studies.
The study, titled “Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders” and published 15 May 2012, followed 762 people diagnosed with psychiatric disorders for 10 years. The death rate after 5 years was 7.5% in non-pot users and 3.1% in those who used pot. After 10 years, the death rate in non-pot users was 13.6%, and 5.5% in pot users.
That is, pot abstainers died at nearly 2½ times the rate of pot users.